Teligent Income from Continuous Operations 2010-2021 | TLGT
Teligent income from continuous operations from 2010 to 2021. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Teligent Annual Income from Continuous Operations
(Millions of US $) |
| 2020 |
$-122 |
| 2019 |
$-25 |
| 2018 |
$-36 |
| 2017 |
$-15 |
| 2016 |
$-12 |
| 2015 |
$7 |
| 2014 |
$5 |
| 2013 |
$-0 |
| 2012 |
$-4 |
| 2011 |
$-3 |
| 2010 |
$-3 |
| 2009 |
$-5 |
Teligent Quarterly Income from Continuous Operations
(Millions of US $) |
| 2021-06-30 |
$-13 |
| 2021-03-31 |
$2 |
| 2020-12-31 |
$-80 |
| 2020-09-30 |
$-1 |
| 2020-06-30 |
$-14 |
| 2020-03-31 |
$-27 |
| 2019-12-31 |
$-5 |
| 2019-09-30 |
$-7 |
| 2019-06-30 |
$-4 |
| 2019-03-31 |
$-9 |
| 2018-12-31 |
$-14 |
| 2018-09-30 |
$-4 |
| 2018-06-30 |
$-13 |
| 2018-03-31 |
$-5 |
| 2017-12-31 |
$-6 |
| 2017-09-30 |
$-9 |
| 2017-06-30 |
$-1 |
| 2017-03-31 |
$1 |
| 2016-12-31 |
$-5 |
| 2016-09-30 |
$-3 |
| 2016-06-30 |
$-3 |
| 2016-03-31 |
$-1 |
| 2015-12-31 |
$-6 |
| 2015-09-30 |
$-3 |
| 2015-06-30 |
$9 |
| 2015-03-31 |
$7 |
| 2014-12-31 |
$6 |
| 2014-09-30 |
$-0 |
| 2014-06-30 |
$-0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$1 |
| 2013-09-30 |
$-0 |
| 2013-06-30 |
$-0 |
| 2013-03-31 |
$-0 |
| 2012-12-31 |
$-1 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-1 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-0 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-1 |
| 2009-12-31 |
$-1 |
| 2009-09-30 |
$-1 |
| 2009-06-30 |
$-2 |
| 2009-03-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
